Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 17/2018

Content (10 Articles)

Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court’s Recent Rulings do not Solve Fundamental Barriers to Competition

  • Current Opinion

Brian K. Chen, Y. Tony Yang, Charles L. Bennett

A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension

  • Review Article

Arrigo F. G. Cicero, Masanari Kuwabara, Claudio Borghi

Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis

  • Systematic Review

Simona Lattanzi, Francesco Brigo, Eugen Trinka, Gaetano Zaccara, Claudia Cagnetti, Cinzia Del Giovane, Mauro Silvestrini

Tapentadol Prolonged Release: A Review in Pain Management

  • Open Access
  • Adis Drug Evaluation

Emma D. Deeks

Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection

  • Open Access
  • Adis Drug Evaluation

Emma D. Deeks

Fremanezumab: First Global Approval

  • Open Access
  • AdisInsight Report

Sheridan M. Hoy

Vibegron: First Global Approval

  • AdisInsight Report

Susan J. Keam

Cemiplimab: First Global Approval

  • AdisInsight Report

Anthony Markham, Sean Duggan

Duvelisib: First Global Approval

  • AdisInsight Report

Hannah A. Blair

Correction to: Elagolix: First Global Approval

  • Open Access
  • Correction

Yvette N. Lamb

Oct 18
Issue: 15/2018
Nov 18
Issue: 16/2018

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images